Oxaliplatin-induced neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin

Journal of Pain

Volumn 13, Issue 3, 2012, Pages 276-284

  Di Cesare Mannelli, Lorenzo ^a   Zanardelli, Matteo ^a   Failli, Paola ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

tocopherol; carbonylated protein; disease modifying agent; lipoperoxidation; Neuropathic pain

Indexed keywords

ALPHA TOCOPHEROL; DNA; OXALIPLATIN; SILIBININ; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; DRUG INDUCED DISEASE; IN VIVO STUDY; LIPID OXIDATION; MALE; MECHANICAL STIMULATION; MOTOR PERFORMANCE; NEUROPATHY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; RAT; SCIATIC NERVE; THERMAL STIMULATION; TREATMENT DURATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; MALE; ORGANOPLATINUM COMPOUNDS; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SILYMARIN;

EID: 84857786335     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2011.11.009     Document Type: Article

References (51)

1. L. Abenavoli, R. Capasso, N. Milic, and F. Capasso Milk thistle in liver diseases: Past, present, future Phytother Res 24 2010 1423 1432
2. J.W. Albers, V. Chaudry, G. Cavaletti, and R.C. Donehower Intervention for preventive neuropathy caused by cisplatin and related compound Cochrane Database Syst Rev 2011 CD005228
3. T. Andre, M. Bensmaine, C. Louvet, E. Francois, V. Lucas, F. Desseigne, K. Beerblock, O. Bouché, E. Carola, Y. Merrouche, F. Morvan, G. Dupont-André, and A. de Gramont Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen J Clin Oncol 17 1999 3560 3568 (Pubitemid 29517928)
4. A.A. Argyriou, E. Chroni, A. Koutras, G. Iconomou, S. Papapetropoulos, P. Polychronopoulos, and H.P. Kalofonos A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: Final results Support Care Cancer 14 2006 1134 1140 (Pubitemid 44898796)
5. M.S. Beg, R.S. Komrokji, K. Ahmed, and M.M. Safa Oxaliplatin-induced immune mediated thrombocytopenia Cancer Chemother Pharmacol 62 2008 925 927
6. S. Cascinu, L. Cordella, E. Del Ferro, M. Fronzoni, and G. Catalano Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled trial J Clin Oncol 13 1995 26 32
7. S. Cascinu, V. Catalano, L. Cordella, R. Labianca, P. Giordani, A.M. Baldelli, G.D. Beretta, E. Ubiali, and G. Catalano Neuroprotective effect of reduced glutathione on oxaliplatinbased chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial J Clin Oncol 20 2002 3478 3483
8. G. Cavaletti, G. Tredici, M.G. Petruccioli, E. Dond, P. Tredici, P. Marmiroli, C. Minoia, A. Ronchi, M. Bayssas, and G.G. Erienne Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat Eur J Cancer 37 2001 2457 2463 (Pubitemid 33097486)
9. R.J. Cersosimo Oxaliplatin-associated neuropathy: A review Ann Pharmacother 39 2005 128 135 (Pubitemid 40052388)
10. C.W. Cheung, P.J. Taylor, C.M. Kirkpatrick, D.A. Vesey, G.C. Gobe, C. Winterford, D.L. Nicol, and D.W. Johnson Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels BJU Int 100 2007 438 444 (Pubitemid 47036591)
11. S.C. Chu, H.L. Chiou, P.N. Chen, S.F. Yang, and Y.S. Hsieh Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2 Mol Carcinogen 40 2004 143 149
12. E. Díaz-Rubio, J. Sastre, A. Zaniboni, R. Labianca, H. Cortés-Funes, F. de Braud, C. Boni, M. Benavides, G. Dallavalle, and M. Homerin Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study Ann Oncol 9 1998 105 108 (Pubitemid 28125772)
13. M. Disatnik, J.S. Chamberlain, and T.A. Rando Dystrophin mutations predict cellular susceptibility to oxidative stress Muscle Nerve 23 2000 784 792 (Pubitemid 30256611)
14. J.-M. Extra, M. Marty, S. Brienza, and J.-L. Misset Pharmacokinetics and safety profile of oxaliplatin Semin Oncol 25 1998 13 22 (Pubitemid 28248697)
15. K. Falasca, C. Ucciferri, P. Mancino, E. Vitacolonna, D. De Tullio, E. Pizzigallo, P. Conti, and J. Vecchiet Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection J Med Virol 80 2008 1900 1906
16. L.F. Ferrari, A. Chum, O. Bogen, D.B. Reichling, and J.D. Levine Role of Drp1, a key mitochondrial fission protein, in neuropathic pain J Neurosci 31 2011 11404 11410
17. E. Gamelin, L. Gamelin, L. Bossi, and S. Quasthoff Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures Semin Oncol 29 2002 21 33 (Pubitemid 35191038)
18. C. Garufi, S. Vaglio, S. Brienza, L. Conti, R.M. D'Attino, G. Girelli, and E. Terzoli Immunohemolytic anemia following oxaliplatin administration Ann Oncol 11 2000 497 (Pubitemid 30333559)
19. Haddad Y, Vallerand D, Brault A, Haddad PS: Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis. Evid Based Complement Alternat Med 2009 Nov 1; [Epub ahead of print]
20. J.E. Hammack, J.C. Michalak, C.L. Loprinzi, J.A. Sloan, P.J. Novotny, G.S. Soori, M.T. Tirona, K.M. Rowland Jr., P.J. Stella, and J.A. Johnson Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Pain 98 2002 195 203 (Pubitemid 34722482)
21. Y.S. Hsieh, S.C. Chu, S.F. Yang, P.N. Chen, Y.C. Liu, and K.H. Lu Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2 Carcinogenesis 28 2007 977 987
22. S.S. Jacobs, E. Fox, C. Dennie, L.B. Morgan, C.L. McCully, and F.M. Balis Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates Clin Cancer Res 11 2005 1669 1674 (Pubitemid 40315252)
23. S.S. Jacobs, C.L. McCully, R.F. Murphy, J. Bacher, F.M. Balis, and E. Fox Extracellular fluid concentrations of cisplatin, carboplatin and oxaliplatin in brain, muscle and blood measured using microdialysis in nonhuman primates Cancer Chemoter Pharmacol 65 2010 817 824
24. T.J. Kaley, and L.M. Deangelis Therapy of chemotherapy-induced peripheral neuropathy Br J Haematol 145 2009 153
25. L.A. Kottschade, J.A. Sloan, M.A. Mazurczak, D.B. Johnson, B.P. Murphy, K.M. Rowland, D.A. Smith, A.R. Berg, P.J. Stella, and C.L. Loprinzi The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: Results of a randomized phase III clinical trial Support Care Cancer 19 2011 1769 1777
26. J.J. Lah, W. Cui, and K.O. Hu Effects and mechanisms of silibinin on human hepatoma cell lines World J Gastroenterol 13 2007 5299 5305 (Pubitemid 47559458)
27. G.E. Leighton, R.E. Rodriguez, R.G. Hill, and J. Hughes k-opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat Br J Pharmacol 93 1988 553 560 (Pubitemid 18073267)
28. J. Leinonen, T. Lehtimäki, S. Toyokuni, K. Okada, T. Tanaka, H. Hiai, H. Ochi, P. Laippala, V. Rantalaiho, O. Wirta, A. Pasternack, and H. Alho New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus FEBS Lett 417 1997 150 152 (Pubitemid 27490491)
29. P.C. Lin, M.Y. Lee, W.S. Wang, C.C. Yen, T.C. Chao, L.T. Hsiao, M.H. Yang, P.M. Chen, K.P. Lin, and T.J. Chiou N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data Support Care Cancer 14 2006 484 487
30. C. Loguercio, and D. Festi Silybin and the liver: From basic research to clinical practice World J Gastroenterol 17 2011 2288 2301
31. P. Lu, T. Mamiya, L.L. Lu, A. Mouri, M. Niwa, M. Hiramatsu, L.B. Zou, T. Nagai, T. Ikejima, and T. Nabeshima Silibinin attenuates amyloid beta25-35 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice JPET 331 2009 319 326
32. P. Muriel, M.G. Moreno, C. Hernández Mdel, E. Chávez, and L.K. Alcantar Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: Effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid Basic Clin Pharmacol Toxicol 96 2005 375 380 (Pubitemid 40676591)
33. National Toxicology Program Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies) Natl Toxicol Program Tech Rep Ser 565 2011 1 177
34. R. Nassini, M. Gees, S. Harrison, G. De Siena, S. Materazzi, N. Moretto, P. Failli, D. Preti, N. Marchetti, A. Cavazzini, F. Mancini, P. Pedretti, B. Nilius, R. Patacchini, and P. Geppetti Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation Pain 152 2011 1621 1631
35. A. Pace, A. Savarese, M. Picardo, V. Maresca, U. Pacetti, G. Del Monte, A. Biroccio, C. Leonetti, B. Jandolo, F. Cognetti, and L. Bove Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy J Clin Oncol 21 2003 927 931 (Pubitemid 46606454)
36. H. Pan, P. Mukhopadhyay, V. Rajesh, B. Mukhopadhyay, B. Gao, G. Hasko, and P. Pacher Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death J Pharm Exp Ther 3 2009 708 714
37. S.A. Park, K.S. Choi, J.H. Bang, K. Huh, and S.U. Kim Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand J Neurochem 75 2000 946 953 (Pubitemid 30660482)
38. M. Penz, G.V. Kornek, M. Raderer, H. Ulrich-Pur, W. Fiebiger, and W. Scheithauer Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy Ann Oncol 12 2001 421 422 (Pubitemid 32288702)
39. J. Post-White, E.J. Ladas, and K.M. Kelly Advances in the use of milk thistle (Silybum marianum) Integr Cancer Ther 6 2007 104 109 (Pubitemid 46871842)
40. M. Provinciali, F. Papalini, F. Orlando, S. Pierpaoli, A. Donnini, P. Morazzoni, A. Riva, and A. Smorlesi Effect of the silybin phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice Cancer Res 67 2007 2022 2029 (Pubitemid 46424219)
41. K. Ramasamy, and R. Agarwal Multitargeted therapy of cancer by silymarin Cancer Lett 269 2008 352 362
42. M.L. Rothenberg, A.M. Oza, R.H. Bigelow, J.D. Berlin, J.L. Marshall, R.K. Ramanathan, L.L. Hart, S. Gupta, C.A. Garay, B.G. Burger, N. Le Bail, and D.G. Haller Superiority of oxaliplatin and fluorouracil leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial J Clin Oncol 21 2003 2059 2069 (Pubitemid 46606353)
43. M. Sakurai, N. Egashira, T. Kawashiri, T. Yano, H. Ikesue, and R. Oishi Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia Pain 147 2009 165 174
44. R. Saller, R. Meier, and R. Brignoli The use of silymarin in the treatment of liver diseases Drugs 61 2001 2035 2063 (Pubitemid 33135182)
45. J. Shen, P. Deininger, J.D. Hunt, and H. Zhao 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer Cancer 109 2007 574 580 (Pubitemid 46190966)
46. R.P. Singh, and R. Agarwal Prostate cancer chemoprevention by silibinin: Bench to bedside Mol Carcinogen 45 2006 436 442 (Pubitemid 43865852)
47. L.E. Ta, L. Espeset, J. Podratz, and A.J. Windebank Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding Neurotoxicology 27 2006 992 1002 (Pubitemid 44838955)
48. B.M. Taleghani, O. Meyer, S. Fontana, N. Ahrens, U. Novak, M.M. Borner, and A. Salama Oxaliplatin-induced immune pancytopenia Transfusion 8 2005 704 708 (Pubitemid 40656382)
49. A.R. Tomé, D. Feng, and R.M. Freitas The effects of alpha-tocopherol on hippocampal oxidative stress prior to in pilocarpine-induced seizures Neurochem Res 35 2010 580 587
50. R.M. Vigueras-Villaseñor, I. Ojeda, O. Gutierrez-Pérez, M. Chavez-Saldaña, O. Cuevas, D.S. Maria, and J.C. Rojas-Castañeda Protective effect of α-tocopherol on damage to rat testes by experimental cryptorchidism Int J Exp Pathol 92 2011 131 139
51. H. Zheng, W.H. Xiao, and G.J. Bennett Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy Exp Neurol 232 2011 154 161